Yra.no
company

ALGINOR PHARMA INGREDIENTS AS

5525 HAUGESUND

Overview

Finances

Roles & Owners
Share Ownership
Return on Equity
−0,9 %
Current Ratio
16,45
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue400 000
Net Income−89 000
Total Assets10 395 000
Total Equity9 911 000
Income (NOK)2022
Revenue400 000
Expenditure489 000
Operating Profit−89 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−89 000
Tax0
Net Income−89 000
Balance (NOK)2022
Total Fixed Assets2 434 000
Total Current Assets7 961 000
Total Assets10 395 000
Total Retained Equity−89 000
Total Equity9 911 000
Total Long-Term Debt0
Total Current Debt484 000
Total Equity and Debt10 395 000
Cash flow (NOK)2022
Sales Income0
Other Income400 000
Revenue400 000
Cost of Goods Sold440 000
Salary Costs0
Depreciation0
Impairment0
Expenditure489 000
Operating Profit−89 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−89 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets2 434 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets2 434 000
Stock0
Total Investments0
Cash, Bank5 839 000
Total Current Assets7 961 000
Total Assets10 395 000
Total Equity9 911 000
Short-Term Group Debt484 000
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt484 000
Total Equity and Debt10 395 000
Financial indicators2022
Return on Equity−0,9 %
Debt-to-Equity Ratio0
Operating Profit Margin−22,25 %
Current Ratio16,45
Quick Ratio16,45
Equity Ratio0,95
Gross Profit Margin−10 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English